Hospital Sírio-Libanês

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Prostate cancer2 trials
• Gastric and oesophageal cancer1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 34 trials

Status

• Active, not recruiting3 trials
• Recruiting1 trial

Lead sponsor

• Daiichi Sankyo1 trial
• Hoffmann-La Roche1 trial
• Memorial Sloan Kettering Cancer Center1 trial
• Pfizer1 trial

Running trials

• Recruiting

  A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

  NCT06629779· Phase 3· Pfizer· Source

• Active, not recruiting

  A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)

  NCT06065748· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

  NCT04704934· Phase 3· Daiichi Sankyo· Source

• Active, not recruiting

  A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer

  NCT03574571· Phase 3· Memorial Sloan Kettering Cancer Center· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Prostate cancer1 recruiting